What Technology Does NIPT Use for Prenatal Screening?

Discover how Non-Invasive Prenatal Testing (NIPT) uses cell-free DNA technology to detect fetal chromosomal abnormalities safely and accurately.

75 views

Non-Invasive Prenatal Testing (NIPT) uses cutting-edge cell-free DNA (cfDNA) technology. Through a simple blood draw from the mother, cfDNA technology analyzes genetic material from the placenta that circulates in the mother’s blood. This allows for the detection of potential chromosomal abnormalities in the fetus, such as Down syndrome, Edwards syndrome, and Patau syndrome, with high accuracy and minimal risk to both mother and fetus.

FAQs & Answers

  1. How accurate is NIPT technology in detecting chromosomal abnormalities? NIPT using cell-free DNA technology is highly accurate in detecting common chromosomal abnormalities such as Down syndrome, Edwards syndrome, and Patau syndrome, with detection rates often exceeding 99%.
  2. Is NIPT safe for both mother and fetus? Yes, NIPT is a non-invasive procedure that requires only a maternal blood draw, posing minimal risk to both mother and fetus compared to invasive diagnostic tests.
  3. What conditions can NIPT detect using cfDNA technology? NIPT can detect chromosomal abnormalities including trisomies like Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), and Patau syndrome (trisomy 13) by analyzing cell-free DNA from the placenta.
  4. When is the best time to perform NIPT during pregnancy? NIPT is typically performed after the 10th week of pregnancy when enough fetal cfDNA circulates in the maternal blood for accurate analysis.